Oligodendroglioma surgery: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
 
(11 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Oligodendroglioma}}
{{Oligodendroglioma}}
{{CMG}}{{AE}}{{SR}}
{{CMG}}{{AE}}{{S.M.}}{{SR}}


==Overview==
==Overview==
[[Surgery]] is the first-line treatment option for patients with oligodendroglioma.<ref name=rx>Treatment of oligodendroglioma. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/oligodendroglioma/?region=on</ref> [[Hydrocephalus surgery|CSF shunting]] is usually reserved for patients with [[hydrocephalus]].<ref name="pmid20052406">{{cite journal| author=Stark AM, Hugo HH, Mehdorn HM, Knerlich-Lukoschus F| title=Acute Hydrocephalus due to Secondary Leptomeningeal Dissemination of an Anaplastic Oligodendroglioma. | journal=Case Rep Med | year= 2009 | volume= 2009 | issue=  | pages= 370901 | pmid=20052406 | doi=10.1155/2009/370901 | pmc=PMC2797365 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20052406  }} </ref>
[[Surgery]] is the first-line [[Treatment IND|treatment]] option for [[patients]] with [[oligodendroglioma]]. However, [[oligodendrogliomas]] cannot be completely [[Resection|resected]] because of their [[Diffuse|diffusely]] [[Infiltration (medical)|infiltrating]] [[nature]]. The aim of [[surgery]] is to make a [[Definitive host|definitive]] [[diagnosis]], [[Debulking|debulk]] the [[tumor]] to relieve [[elevated intracranial pressure]] and [[Reduced|reduce]] the [[Tumor|tumor mass]] as a [[precursor]] to [[Adjuvant treatment|adjuvant treatment.]] [[Hydrocephalus surgery|CSF shunting]] is usually reserved for [[patients]] with [[hydrocephalus]] and includes two types of [[shunts]]: external [[ventricular]] [[Drain (surgery)|drain]]-temporary [[Shunt (medical)|shunt]] and [[internal]] [[Drain (surgery)|drain]]-permanent [[Shunt (medical)|shunt]].


==Surgery==
==Surgery==
===Surgical Resection===
===Surgical Resection===
*[[Surgery|Surgical resection]] is the first-line treatment option for patients with oligodendroglioma.<ref name=rx>Treatment of oligodendroglioma. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/oligodendroglioma/?region=on</ref>
*[[Surgery|Surgical resection]] is the first-line [[Treatments|treatment]] option for [[patients]] with [[oligodendroglioma|oligodendroglioma.]]<ref name="rx">Treatment of oligodendroglioma. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/oligodendroglioma/?region=on</ref><ref name="pmid30467813">{{cite journal| author=Delev D, Heiland DH, Franco P, Reinacher P, Mader I, Staszewski O et al.| title=Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system. | journal=J Neurooncol | year= 2019 | volume= 141 | issue= 1 | pages= 223-233 | pmid=30467813 | doi=10.1007/s11060-018-03030-w | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30467813  }} </ref><ref name="pmid27401154">{{cite journal| author=Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T et al.| title=Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. | journal=J Neurooncol | year= 2016 | volume= 129 | issue= 3 | pages= 505-514 | pmid=27401154 | doi=10.1007/s11060-016-2201-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27401154  }} </ref>
*Because of their diffusely infiltrating nature, oligodendrogliomas cannot be completely resected.
*Because of their [[Diffuse|diffusely]] [[Infiltration (medical)|infiltrating]] [[nature]], [[oligodendrogliomas]] cannot be completely [[Resection|resected]].
*The aim of surgery is to:<ref name="pmid15509821">{{cite journal| author=Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN| title=Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 18 | pages= 1875-82 | pmid=15509821 | doi=10.1056/NEJMcpc049025 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15509821  }} </ref>
*The aim of [[surgery]] is to:<ref name="pmid15509821">{{cite journal| author=Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN| title=Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 18 | pages= 1875-82 | pmid=15509821 | doi=10.1056/NEJMcpc049025 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15509821  }} </ref>
**Make a definitive diagnosis
**Make a definitive [[diagnosis]]
**Debulk the [[tumor]] to relieve [[elevated intracranial pressure]]
**[[Debulking|Debulk]] the [[tumor]] to relieve [[elevated intracranial pressure]]
**Reduce the [[tumor|tumor mass]] as a precursor to adjuvant treatment
**[[Reduced|Reduce]] the [[tumor|tumor mass]] as a [[precursor]] to [[adjuvant treatment]]


===CSF Shunt===
===CSF Shunt===
*[[Hydrocephalus surgery|CSF shunting]] is performed to relieve the pressure in the brain due to blockade in the flow of cerebrospinal fluid due to oligodendroglioma.<ref name="pmid20052406">{{cite journal| author=Stark AM, Hugo HH, Mehdorn HM, Knerlich-Lukoschus F| title=Acute Hydrocephalus due to Secondary Leptomeningeal Dissemination of an Anaplastic Oligodendroglioma. | journal=Case Rep Med | year= 2009 | volume= 2009 | issue=  | pages= 370901 | pmid=20052406 | doi=10.1155/2009/370901 | pmc=PMC2797365 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20052406  }} </ref>
*[[Hydrocephalus surgery|CSF shunting]] is [[Performance status|performed]] to relieve the [[pressure]] in the [[brain]] due to [[Blocking (statistics)|blockade]] in the [[flow]] of [[cerebrospinal fluid]] due to [[oligodendroglioma|oligodendroglioma.]]<ref name="pmid20052406">{{cite journal| author=Stark AM, Hugo HH, Mehdorn HM, Knerlich-Lukoschus F| title=Acute Hydrocephalus due to Secondary Leptomeningeal Dissemination of an Anaplastic Oligodendroglioma. | journal=Case Rep Med | year= 2009 | volume= 2009 | issue=  | pages= 370901 | pmid=20052406 | doi=10.1155/2009/370901 | pmc=PMC2797365 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20052406  }} </ref>
**External ventricular drain - temporary shunt
**External [[ventricular]] [[Drain (surgery)|drain]] (temporary [[shunt|shunt)]]
**Internal drain - permanent shunt
**[[Internal]] [[Drain (surgery)|drain]] (permanent [[shunt]])
***Drains CSF into the patient’s abdomen where it is absorbed into the body
***[[Drain (surgery)|Drains]] [[CSF]] into the [[Patient|patient’s]] [[abdomen]] where it is [[Absorption|absorbed]] into the [[Human body|body]]


==References==
==References==

Latest revision as of 17:46, 3 June 2019

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma surgery

CDC on Oligodendroglioma surgery

Oligodendroglioma surgery in the news

Blogs on Oligodendroglioma surgery

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]

Overview

Surgery is the first-line treatment option for patients with oligodendroglioma. However, oligodendrogliomas cannot be completely resected because of their diffusely infiltrating nature. The aim of surgery is to make a definitive diagnosis, debulk the tumor to relieve elevated intracranial pressure and reduce the tumor mass as a precursor to adjuvant treatment. CSF shunting is usually reserved for patients with hydrocephalus and includes two types of shunts: external ventricular drain-temporary shunt and internal drain-permanent shunt.

Surgery

Surgical Resection

CSF Shunt

References

  1. Treatment of oligodendroglioma. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/oligodendroglioma/?region=on
  2. Delev D, Heiland DH, Franco P, Reinacher P, Mader I, Staszewski O; et al. (2019). "Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system". J Neurooncol. 141 (1): 223–233. doi:10.1007/s11060-018-03030-w. PMID 30467813.
  3. Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T; et al. (2016). "Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion". J Neurooncol. 129 (3): 505–514. doi:10.1007/s11060-016-2201-2. PMID 27401154.
  4. Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN (2004). "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion". N Engl J Med. 351 (18): 1875–82. doi:10.1056/NEJMcpc049025. PMID 15509821.
  5. Stark AM, Hugo HH, Mehdorn HM, Knerlich-Lukoschus F (2009). "Acute Hydrocephalus due to Secondary Leptomeningeal Dissemination of an Anaplastic Oligodendroglioma". Case Rep Med. 2009: 370901. doi:10.1155/2009/370901. PMC 2797365. PMID 20052406.


Template:WikiDoc Sources